Apellis Pharmaceuticals I... (APLS)
NASDAQ: APLS
· Real-Time Price · USD
27.77
0.15 (0.54%)
At close: Aug 15, 2025, 3:59 PM
28.85
3.91%
After-hours: Aug 15, 2025, 04:56 PM EDT
Apellis Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -42.15M | -92.22M | -36.35M | -57.45M | -37.66M | -66.42M | -88.58M | -140.24M | -122.04M | -177.78M | -165.99M | -191.27M | -155.98M | -138.94M | -147.93M | -195.57M | -219.19M | -183.66M |
Depreciation & Amortization | 446K | 446K | 447K | 457K | 449K | 444K | 490K | 405K | 410K | 399K | 428K | 357K | 342K | 360K | 376K | 274K | 448K | 394K |
Stock-Based Compensation | 27.2M | 27.37M | 26.31M | 27.48M | 29.99M | 30.35M | 26.22M | 21.63M | 29.28M | 28.82M | 24.24M | 23.54M | 22.53M | 20.77M | 19.31M | 17.19M | 17.72M | 16.44M |
Other Working Capital | n/a | -49.98M | 2.76M | 29.87M | 33.42M | -16.43M | 22.81M | 5.79M | 36.72M | 29.49M | -1.95M | -9.5M | 26.78M | 17.31M | -32.36M | -58.73M | 49.96M | -40.92M |
Other Non-Cash Items | 29.36M | 591K | 587K | 822K | 75.54M | 124.44M | 6.68M | 6.49M | 6.52M | 6.72M | 5M | 41.36M | 7.13M | 8.06M | 1.33M | 2.65M | 319K | 2.03M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -133K | 133K | n/a | n/a | n/a | n/a | n/a | n/a | 55.19M | 65.32M | 21.18M | 56.57M |
Change in Working Capital | -10.4M | 10.4M | 28.36M | 62.79M | -6.18M | -103.5M | -42.56M | -57.5M | -64.33M | -35.79M | -4.42M | -28.4M | 18.95M | -1.82M | -40.78M | -58.49M | 50.83M | -45.09M |
Operating Cash Flow | 4.45M | -53.41M | 19.36M | 34.1M | -8.34M | -132.98M | -97.88M | -169.09M | -150.16M | -177.62M | -140.74M | -154.42M | -107.02M | -111.56M | -112.5M | -168.63M | -128.69M | -153.31M |
Capital Expenditures | -49K | -8K | -20K | n/a | -90K | -293K | -95K | -47K | -372K | -259K | -851K | -196K | -391K | -86K | -19K | -352K | -248K | -484K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 99K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 331.86M | n/a | -331.86M | -331.86M | -1K | 1K | n/a | -171.28M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 124.98M | 124.98M | 83.32M | 60M | 85M | 180M | 130M | 25M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 99K | n/a | n/a | n/a | -331.86M | 124.98M | 331.86M | -271.86M | 85M | 180M | 130M | -146.28M |
Investing Cash Flow | -49K | -8K | -20K | n/a | -90K | -293K | 4K | -47K | -372K | -259K | 124.13M | 124.78M | 82.93M | -271.95M | 84.98M | 179.65M | 129.75M | -146.76M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 2.19M | n/a | n/a | 3.22M | n/a | n/a | -2K | -11K | -28K | n/a | 4.24M | -1M | -536K | n/a | n/a | -361K | -234K | -956K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | -1.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.37M | 274K | -4M | 2.54M | 42.49M | 9.45M | -2.35M | 5.75M | 1.56M | 6.72M | -14.22M | 9.64M | -12.04M | -3.42M | 3.6M | 2.12M | 4.53M | 1.63M |
Financial Cash Flow | 6.56M | 274K | -4M | 2.54M | 42.49M | 108.21M | -3.91M | 5.75M | 1.56M | 391.11M | -15.95M | 9.64M | -4.74M | 376.7M | 383.96M | 2.12M | 4.53M | 1.63M |
Net Cash Flow | 11.64M | -52.78M | 14.38M | 36.81M | 34.4M | -25.27M | -101.2M | -163.84M | -149.01M | 213.28M | -32.37M | -20.31M | -29.26M | -6.74M | 356.45M | 12.97M | 5.35M | -300.06M |
Free Cash Flow | 4.4M | -53.42M | 19.34M | 34.1M | -8.43M | -133.28M | -97.97M | -169.13M | -150.53M | -177.88M | -141.59M | -154.61M | -107.42M | -111.65M | -112.52M | -168.98M | -128.94M | -153.8M |